Trial NCT01034657

View at ClinicalTrials.gov 
Org. Study IDs: CLBH589BDE04
Secondary IDs: 2009-010403-84

Last trial update was posted on 2017-08-11

MeSH Interventions

Epoetin Alfa Panobinostat

MeSH Conditions

Myelodysplastic Syndromes Preleukemia Syndrome

Other Conditions

Myelodysplastic Syndrome (MDS)

Stopping Reasons

The study was terminated due to lack of efficacy of single agent LBH589 in the 4 month open label core phase and due to enrollment difficulties.

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID